December 2012
Lewin contact: Grace Yang
Lewin senior researchers just published an article in the December 2012 issue of Health Affairs on the long-term health and economic implications of smoking cessation in the Military. The article, "Simulation Of Quitting Smoking In The Military Shows Higher Lifetime Medical Spending More Than Offset By Productivity Gains" is based on a Lewin study for the Department of Defense using Lewin's Health Promotion Microsimulation Model. The study found that cessation accompanied by weight gain would increase average life expectancy by 3.7 years, and that the average lifetime medical expenditures would increase slightly as a result of prolonged life. Avoidance of weight gain after quitting smoking would increase average life expectancy by four additional months and reduce mean extra spending. Overall, the average net lifetime health care cost increase of $1,700 or less per ex-smoker would be modest and, for employed people, more than offset by even one year’s worth of productivity gains. These results boost the case for smoking cessation programs in the military.
Client Area: Federal Government
Expertise Area: Chronic Disease / Cost of Illness
January 2012
The US Preventive Services Task Force Should Consider A Broader Evidence Base In Updating Its Diabetes Screening Guidelines
Lewin Contact: Cliff Goodman
The Lewin Group published a new report in the January 2012 thematic issue of Health Affairs on Confronting The Growing Diabetes Crisis. The article, "The US Preventive Services Task Force Should Consider A Broader Evidence Base In Updating Its Diabetes Screening Guidelines" discusses the merits of broadening the types of items considered in diabetes screening in order to facilitate the prevention and early treatment of diabetes. Read more at http://content.healthaffairs.org/content/31/1/35
Expertise Area: Chronic Disease / Cost of Illness, Evidence-Based Medicine / HTA
October 2011
Centers for Disease Control and Prevention
Excessive alcohol use is responsible for an average of 79,000 deaths and 2.3 million years of potential life lost in the United States each year, making it the third leading preventable cause of death in this country. In addition to premature mortality, excessive alcohol consumption affects us all through consequences such as additional health care costs, property damage from fire and motor vehicle crashes, increased crime and criminal justice system costs, and lost productivity. The most recent detailed study of the economic costs of excessive alcohol consumption was conducted in 1998, and produced an estimate for 1992. Since then, there have been significant advances in our scientific understanding of the health and social impacts of excessive drinking.
Given the huge public health impact of excessive alcohol consumption and the improvements in scientific understanding since the prior estimates the CDC Alcohol Team, with generous support from the Robert Wood Johnson Foundation, engaged The Lewin Group to develop updated estimates of the economic cost of excessive alcohol consumption in the U.S. The purpose of the study was develop a more current estimate of the economic cost of excessive alcohol consumption in the U.S. and also to estimate the cost of binge drinking, drinking by underage youth, and drinking during pregnancy. Estimates were developed for 2006, the most recent year for which cost and outcome data were generally available.
A companion article based on this study was also published in the American Journal of Preventive Medicine at http://www.ajpmonline.org/article/S0749-3797%2811%2900538-1/abstract
Client Area: Federal Government
Expertise Area: Chronic Disease / Cost of Illness
September 2010
From the journal CHILDHOOD OBESITY, August 2010, Volume 6, Number 4
Lewin Contact: Anjali Jain
Anjali Jain, MD, a Senior Researcher and Managing Consultant at The Lewin Group, participated in a Roundtable Discussion that was published in the journal CHILDHOOD OBESITY, August 2010, Volume 6, Number 4
Used with the permission of Mary Ann Liebert, Inc., publishers. The inaugural issue of Childhood Obesity, in which the Roundtable Discussion appears, is available online at: http://www.liebertonline.com/chi
Expertise Area: Children, Youth, and Family Policy, Chronic Disease / Cost of Illness
June 2010
City and County of San Francisco
The purpose of this study was to estimate a portion of the health-related economic costs of the measureable, direct effects of alcohol consumption to the City and County of San Francisco. These estimates will be used by the City to assess the public health impact of alcohol and inform policy surrounding an alcohol mitigation fee. There are two major components of this study:
- Cost Analysis: Using data collected from City, State and national data sources, we compute the costs of alcohol use to the City, including costs of City-funded alcohol treatment facilities, direct medical costs at City-operated health care facilities, and City paid fire and ambulance response to alcohol-related medical emergencies.
- Fee Calculation: Using alcohol consumption data from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and population estimates from the U.S. Census Bureau, we estimate the aggregate number of alcoholic drinks consumed in the City. We use this estimate to calculate a maximum fee per alcoholic drink (and an equivalent fee per fluid ounce of alcohol) which recovers a portion of the City’s total alcohol attributable costs.
Analyses are supported by a literature review and environmental scan.
Client Area: State and Local Governments
Expertise Area: Chronic Disease / Cost of Illness
March 2010
Lewin Contact: Anjali Jain
Expertise Area: Chronic Disease / Cost of Illness
March 2010
Lewin Contact: Anjali Jain
Expertise Area: Chronic Disease / Cost of Illness
September 2009
Lupus Foundation of America
Lewin contact: Clifford Goodman
The Lupus Foundation of America, Inc. commissioned The Lewin Group to prepare a report focusing on the multi-dimensional challenges related to the development and approval of new therapies to treat lupus and to develop recommendations for a path forward to address the unmet needs of individuals with lupus. The process for developing this report comprised two parts. The first was conducting a series of interviews with lupus experts across the country to identify the main current barriers to lupus drug development and approval. The second was to
convene and facilitate an expert panel to elicit a broad range of informed opinions on obstacles to lupus drug development and approval and possible approaches for overcoming them.
Client Area: Foundations
Expertise Area: Chronic Disease / Cost of Illness
June 2009
Presentation to Capitol Hill Briefing with NCOA 19 June 2009
Lewin Contact: Lisa Alecxih
Consumers in Control: Cost-Effective Chronic Care Strategies for Health Reform
Friday, June 19, 2009
9:30-11:00 am
Lisa
Alecxih, Vice President of the Lewin Group, spoke today at a briefing
on Capitol Hill sponsored by the not-for-profit National Council on
Aging (NCOA), along with other leading health care experts. The
briefing discussed the results of NCOA's national survey of adults with
multiple chronic health conditions. The Capitol Hill briefing
highlighted the day-to-day challenges Americans face in managing their
chronic conditions in a fragmented health system, and showcased models
that are helping consumers regain control of their health.
Expertise Area: Chronic Disease / Cost of Illness, Health Reform
April 2009
Novo Nordisk
For Novo Nordisk, The Lewin Group estimated the economic costs of diagnosed type 1 (T1DM) and type 2 (T2DM) diabetes mellitus in the United States in 2007. Lewin analyzed medical claims to estimate the proportion of diagnosed diabetes cases and excess medical costs by diabetes type. Indirect costs associated with T1DM and T2DM were estimated by using findings from the literature on diagnosed diabetes, as well as differences in health per case of T1DM and T2DM. This study builds on the Cost of Diabetes Model developed by Lewin for the American Diabetes Association to estimate the economic burden of diagnosed diabetes. The study is published in the journal Population Health Management.
Client Area: Pharma / Bio / Device
Expertise Area: Chronic Disease / Cost of Illness
Showing 1 to 10 of 28 item(s)